Bernard Combe

43.9k total citations · 4 hit papers
481 papers, 14.3k citations indexed

About

Bernard Combe is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Bernard Combe has authored 481 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 386 papers in Rheumatology, 136 papers in Hematology and 125 papers in Immunology. Recurrent topics in Bernard Combe's work include Rheumatoid Arthritis Research and Therapies (335 papers), Systemic Lupus Erythematosus Research (142 papers) and Autoimmune and Inflammatory Disorders Research (112 papers). Bernard Combe is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (335 papers), Systemic Lupus Erythematosus Research (142 papers) and Autoimmune and Inflammatory Disorders Research (112 papers). Bernard Combe collaborates with scholars based in France, United States and Netherlands. Bernard Combe's co-authors include Jacques Morel, J Sany, Jean Sibilia, Cédric Lukas, Maxime Dougados, C. Hua, Alain Cantagrel, Thomas Barnetche, Philippe Goupille and Xavier Mariette and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Bernard Combe

452 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

2006 566 citations Bernard Combe, Cédric Lukas et al. Annals of the Rheumatic Diseases profile →
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

2008 465 citations Désirée van der Heijde, Robert Landewé et al. profile →
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

2018 331 citations Bernard Combe et al. profile →
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

2021 163 citations Bernard Combe, Yoshiya Tanaka et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Bernard Combe

Since Specialization

Citations

This map shows the geographic impact of Bernard Combe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Combe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Combe more than expected).

Fields of papers citing papers by Bernard Combe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Combe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Combe. The network helps show where Bernard Combe may publish in the future.

Co-authorship network of co-authors of Bernard Combe

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Combe. A scholar is included among the top collaborators of Bernard Combe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Combe. Bernard Combe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations 2025 ·Rheumatology and Therapy ·Jérôme Avouac, Hafid Ait‐Oufella, (unknown), (unknown), Bernard Combe	2
2	Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses 2023 ·Rheumatology and Therapy ·Yoshiya Tanaka, Tsutomu Takeuchi, Tatsuya Atsumi, Bernard Combe, Daniel Aletaha, Toshihiko Kaise, (unknown)	2
3	OA06 Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions 2023 ·Lara D. Veeken ·Maya H Buch, Bernard Combe, José A. Gómez‐Puerta, Roberto Caporali, Jacques‐Eric Gottenberg, (unknown), (unknown), (unknown), Katrien Van Beneden, Daniel Aletaha, Gerd R Burmester, René Westhovens, Yoshiya Tanaka	1
4	Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception Cohort 2023 ·Joint Bone Spine ·Maxime Dougados, (unknown), Sandrine Alonso, Francis Bérenbaum, Pascal Claudepierre, Bernard Combe, Laure Gossec, (unknown), Alain Saraux, Daniel Wendling, (unknown), Anna Moltó	4
5	Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension 2022 ·RMD Open ·Désirée van der Heijde, Atul Deodhar, Walter P. Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae‐Hwan Kim, Mitsumasa Kishimoto, Andrew J.K. Östör, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter Wung, In‐Ho Song	32
6	The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population 2021 ·Joint Bone Spine ·Jérémie Sellam, E. Maheu, M.D. Crema, (unknown), Alice Courties, Sophie Tuffet, Alexandra Rousseau, Xavier Chevalier, Bernard Combe, Maxime Dougados, Bruno Fautrel, M. Kloppenburg, Jean‐Denis Laredo, Damien Lœuille, Anne Miquel, François Rannou, Pascal Richette, Tabassome Simon, Francis Bérenbaum	22
7	Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries 2020 ·Annals of the Rheumatic Diseases ·Christian Dejaco, Alessia Alunno, J. W. J. Bijlsma, Annelies Boonen, Bernard Combe, Axel Finckh, Pedro Machado, Ivan Padjen, Francisca Sivera, Tanja Stamm, Frank Buttgereit	51
8	EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 2020 ·Annals of the Rheumatic Diseases ·Robert Landewé, Pedro Machado, Féline P B Kroon, Hans Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D. Isaacs, Xavier Mariette, Iain B. McInnes, Ulf Müeller-Ladner, Peter Openshaw, Josef S Smolen, Tanja Stamm, Dieter Wiek, Hendrik Schulze‐Koops	153
9	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study 2019 ·BMJ ·Jacques‐Eric Gottenberg, Jacques Morel, Élodie Perrodeau, Thomas Bardin, Bernard Combe, Maxime Dougados, René‐Marc Flipo, Alain Saraux, Thierry Schaeverbeke, Jean Sibilia, Martin Soubrier, Olivier Vittecoq, Gabriel Baron, Arnaud Constantin, Philippe Ravaud, Xavier Mariette	93
10	Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde 2018 ·Revue du Rhumatisme ·C. Daïen, C. Hua, C. Gaujoux-Viala, Alain Cantagrel, (unknown), Maxime Dougados, Bruno Fautrel, Xavier Mariette, (unknown), Christophe Richez, Alain Saraux, (unknown), Daniel Wendling, Laure Gossec, Bernard Combe	6
11	Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up. 2017 ·PubMed ·Anne Tournadre, Bruno Pereira, Jean‐Jacques Dubost, Nathalie Rincheval, (unknown), Bernard Combe, Martin Soubrier	7
12	Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls 2017 ·PLoS ONE ·(unknown), Guilhem du Cailar, Rachel Audo, Cédric Lukas, Guillaume Vial, Anne Tournadre, (unknown), Jean Ribstein, Bernard Combe, Jacques Morel, C. Daïen	17
13	Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study. 2015 ·PubMed ·Laure Gossec, (unknown), Stéphanie Rouanet, Bernard Combe	32
14	Unmet Needs in the Treatment of Rheumatoid Arthritis 2013 ·Janet Pope, Bernard Combe	10
15	Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria 2012 ·Data Archiving and Networked Services (DANS) ·Walter P. Maksymowych, (unknown), Robert Landewé, (unknown), Joan M. Bathon, (unknown), Vivian P. Bykerk, Mikkel Østergaard, Hilde Berner Hammer, (unknown), (unknown), Oliver FitzGerald, Christopher T. Ritchlin, Dafna D. Gladman, Philip J. Mease, (unknown), M. Backhaus, Bernard Combe, (unknown), A. Marotta	2
16	Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials 2012 ·The Journal of Rheumatology ·(unknown), (unknown), Thomas Barnetche, Jacques Morel, Bernard Combe	30
17	Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis Cohort ESPOIR 2010 ·The Journal of Rheumatology ·Laure Gossec, Christophe Combescure, Nathalie Rincheval, Alain Saraux, Bernard Combe, Maxime Dougados	21
18	Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6months' first-line DMARD therapy 2006 ·Joint Bone Spine ·Olivier Meyer, Michel De Bandt, Jean‐Marie Berthelot, Alain Cantagrel, Bernard Combe, Bruno Fautrel, René‐Marc Flipo, Frédéric Lioté, Jean-Françis Maillefert, Alain Saraux, Daniel Wendling, Françis Guillemin, Xavier Le Loët	14
19	Traduction française et adaptation culturelle du « back book »French translation and cultural adaptation of the “back book” 2003 ·University of Huddersfield Repository (University of Huddersfield) ·Emmanuel Coudeyre, (unknown), (unknown), (unknown), C. Hérisson, Bernard Combe, Kim Burton, Serge Poiraudeau	1
20	Evaluation of efficacy and safety of oral tiludronate in Paget's disease of bone: a double-blind, dose-ranging, placebo-controlled study 1993 ·Open Repository and Bibliography (University of Liège) ·Jean‐Yves Reginster, François Colson, (unknown), Bernard Combe, D Ethgen, Piet Geusens	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact